{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:56:52Z","timestamp":1772585812860,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,11,11]],"date-time":"2006-11-11T00:00:00Z","timestamp":1163203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2006,12,19]]},"DOI":"10.1007\/s00213-006-0619-5","type":"journal-article","created":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T11:52:49Z","timestamp":1163159569000},"page":"221-231","source":"Crossref","is-referenced-by-count":34,"title":["Role of atypical opiates in OCD. Experimental approach through the study of 5-HT2A\/C receptor-mediated behavior"],"prefix":"10.1007","volume":"190","author":[{"given":"M. Olga","family":"Rojas-Corrales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Gibert-Rahola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A.","family":"Mico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,11]]},"reference":[{"key":"619_CR1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S1461145705005055","volume":"8","author":"KH Adams","year":"2005","unstructured":"Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S, Bolwig TG, Knudsen GM (2005) Patients with obsessive\u2013compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol 8:391\u2013401","journal-title":"Int J Neuropsychopharmacol"},{"key":"619_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004850-200205000-00004","volume":"17","author":"M Atmaca","year":"2002","unstructured":"Atmaca M, Kuloglu M, Tezcan E, Gecici O (2002) Quetiapine augmentation in patients with treatment resistant obsessive\u2013compulsive disorder: a single-blind, placebo-controlled study. Int Clin Psychopharmacol 17:115\u2013119","journal-title":"Int Clin Psychopharmacol"},{"key":"619_CR3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083\u20131152","journal-title":"Neuropharmacology"},{"key":"619_CR4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.npp.1300611","volume":"30","author":"M Basselin","year":"2005","unstructured":"Basselin M, Chang L, Seemann R, Bell JM, Rapoport SI (2005) Chronic lithium administration to rats selectively modifies 5-HT2A\/2C receptor-mediated brain signaling via arachidonic acid. Neuropsychopharmacology 30:461\u2013472","journal-title":"Neuropsychopharmacology"},{"key":"619_CR5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s002130050923","volume":"143","author":"PB Bergqvist","year":"1999","unstructured":"Bergqvist PB, Dong J, Blier P (1999) Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study. Psychopharmacology (Berl) 143:89\u201396","journal-title":"Psychopharmacology (Berl)"},{"key":"619_CR6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.biopsych.2005.08.023","volume":"59","author":"A Berney","year":"2006","unstructured":"Berney A, Sookman D, Leyton M, Young SN, Benkelfat C (2006) Lack of effects on core obsessive\u2013compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive\u2013compulsive disorder patients. Biol Psychiatry 59:853\u2013857","journal-title":"Biol Psychiatry"},{"key":"619_CR7","first-page":"1263","volume":"274","author":"EE Codd","year":"1995","unstructured":"Codd EE, Shank RP, Schupsky JJ, Raffa RB (1995) Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther 274:1263\u20131270","journal-title":"J Pharmacol Exp Ther"},{"key":"619_CR8","first-page":"106","volume":"20","author":"SJ Corne","year":"1963","unstructured":"Corne SJ, Pickering R, Warner BJ (1963) A method for assessing the effect of drugs on the central actions of drugs on the central action of 5-hydroxytriptamine. Br J Pharmacol 20:106\u2013120","journal-title":"Br J Pharmacol"},{"key":"619_CR9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0091-3057(94)00340-8","volume":"50","author":"NA Darmani","year":"1995","unstructured":"Darmani NA, Gerdes CF (1995) Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI. Pharmacol Biochem Behav 50:545\u2013550","journal-title":"Pharmacol Biochem Behav"},{"key":"619_CR10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0091-3057(90)90047-L","volume":"37","author":"NA Darmani","year":"1990","unstructured":"Darmani NA, Martin BR, Pandey U, Glennon RA (1990) Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions. Pharmacol Biochem Behav 37:95\u201399","journal-title":"Pharmacol Biochem Behav"},{"key":"619_CR11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(82)90587-8","volume":"79","author":"GM Montis De","year":"1982","unstructured":"De Montis GM, Devoto P, Tagliamonte A (1982) Possible antidepressant activity of methadone. Eur J Pharmacol 79:145\u2013146","journal-title":"Eur J Pharmacol"},{"key":"619_CR12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/02791072.1998.10399711","volume":"30","author":"PL Delgado","year":"1998","unstructured":"Delgado PL, Moreno FA (1998) Hallucinogens, serotonin and obsessive\u2013compulsive disorder. J Psychoact Drugs 30:359\u2013366","journal-title":"J Psychoact Drugs"},{"key":"619_CR13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/jclp.20083","volume":"60","author":"DD Dougherty","year":"2004","unstructured":"Dougherty DD, Rauch SL, Jenike MA (2004) Pharmacotherapy for obsessive\u2013compulsive disorder. J Clin Psychol 60:1195\u20131202","journal-title":"J Clin Psychol"},{"key":"619_CR14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s002130050125","volume":"128","author":"SM Dursun","year":"1996","unstructured":"Dursun SM, Handley SL (1996) Similarities in the pharmacology of spontaneous and DOI-induced head-shakes suggest 5HT2A receptors are active under physiological conditions. Psychopharmacology (Berl) 128:198\u2013205","journal-title":"Psychopharmacology (Berl)"},{"key":"619_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/PL00005486","volume":"146","author":"JL Evenden","year":"1999","unstructured":"Evenden JL, Ryan CN (1999) The pharmacology of impulsive behaviour in rats VI: the effects of ethanol and selective serotonergic drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl) 146:413\u2013421","journal-title":"Psychopharmacology (Berl)"},{"key":"619_CR16","first-page":"442","volume":"32","author":"J Fanelli","year":"1998","unstructured":"Fanelli J, Montgomery C (1998) Use of the analgesic tramadol in antidepressant potentiation. Psychopharmacol Bull 32:442","journal-title":"Psychopharmacol Bull"},{"key":"619_CR17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cpr.2005.06.010","volume":"26","author":"L Friedlander","year":"2006","unstructured":"Friedlander L, Desrocher M (2006) Neuroimaging studies of obsessive\u2013compulsive disorder in adults and children. Clin Psychol Rev 26:32\u201349","journal-title":"Clin Psychol Rev"},{"key":"619_CR18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130000558","volume":"153","author":"CM Gaynor","year":"2001","unstructured":"Gaynor CM, Handley SL (2001) Effects of nicotine on head-shakes and tryptophan metabolites. Psychopharmacology (Berl) 153:327\u2013333","journal-title":"Psychopharmacology (Berl)"},{"key":"619_CR19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1152\/ajplegacy.1962.203.1.167","volume":"203","author":"PK Gessner","year":"1962","unstructured":"Gessner PK, Page IH (1962) Behavioral effects of 5-methoxy-N,N dimethyltryptamine, other tryptamines and L.S.D. Am J Physiol 203:167","journal-title":"Am J Physiol"},{"key":"619_CR20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1176\/ajp.156.4.660a","volume":"156","author":"TB Goldsmith","year":"1999","unstructured":"Goldsmith TB, Shapira NA, Keck PE, Jr. (1999) Rapid remission of OCD with tramadol hydrochloride. Am J Psychiatry 156:660\u2013661","journal-title":"Am J Psychiatry"},{"key":"619_CR21","first-page":"123","volume":"85","author":"AM Graybiel","year":"2001","unstructured":"Graybiel AM, Canales JJ (2001) The neurobiology of repetitive behaviors: clues to the neurobiology of Tourette syndrome. Adv Neurol 85:123\u2013131","journal-title":"Adv Neurol"},{"key":"619_CR22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.pbb.2005.06.010","volume":"81","author":"RL Hayslett","year":"2005","unstructured":"Hayslett RL, Tizabi Y (2005) Effects of donepezil, nicotine and haloperidol on the central serotonergic system in mice: implications for Tourette\u2019s syndrome. Pharmacol Biochem Behav 81:879\u2013886","journal-title":"Pharmacol Biochem Behav"},{"key":"619_CR23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S1461145703003730","volume":"6","author":"E Hollander","year":"2003","unstructured":"Hollander E, Baldini Rossi N, Sood E, Pallanti S (2003) Risperidone augmentation in treatment-resistant obsessive\u2013compulsive disorder: a double-blind, placebo-controlled study. Int J Neuropsychopharmacol 6:397\u2013401","journal-title":"Int J Neuropsychopharmacol"},{"key":"619_CR24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/026988110101500301","volume":"15","author":"SE Hopwood","year":"2001","unstructured":"Hopwood SE, Owesson CA, Callado LF, McLaughlin DP, Stamford JA (2001) Effects of chronic tramadol on pre- and post-synaptic measures of monoamine function. J Psychopharmacol 15:147\u2013153","journal-title":"J Psychopharmacol"},{"key":"619_CR25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0006-8993(95)00865-N","volume":"698","author":"J Ichikawa","year":"1995","unstructured":"Ichikawa J, Meltzer HY (1995) DOI, a 5-HT2A\/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum. Brain Res 698:204\u2013208","journal-title":"Brain Res"},{"key":"619_CR26","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1176\/ajp.140.9.1219","volume":"140","author":"TR Insel","year":"1983","unstructured":"Insel TR, Pickar D (1983) Naloxone administration in obsessive\u2013compulsive disorder: report of two cases. Am J Psychiatry 140:1219\u20131220","journal-title":"Am J Psychiatry"},{"key":"619_CR27","first-page":"229","volume-title":"Handbook of laboratory animal science. Selection and handling of animals in biomedical research","author":"K Iwarson","year":"1994","unstructured":"Iwarson K, Lindberg L, Waller T (1994) Common non-surgical techniques and procedures. In: Svendsen P, Hau J (eds) Handbook of laboratory animal science. Selection and handling of animals in biomedical research. CRC, Boca Raton (Florida), pp 229\u2013272"},{"key":"619_CR28","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/archpsyc.1988.01800360042006","volume":"45","author":"M Karno","year":"1988","unstructured":"Karno M, Golding JM, Sorenson SB, Burnam MA (1988) The epidemiology of obsessive\u2013compulsive disorder in five US communities. Arch Gen Psychiatry 45:1094\u20131099","journal-title":"Arch Gen Psychiatry"},{"key":"619_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pbb.2005.02.010","volume":"81","author":"Y Kawakami","year":"2005","unstructured":"Kawakami Y, Kitamura Y, Araki H, Kitagawa K, Suemaru K, Shibata K, Gomita Y (2005) Effects of monoamine reuptake inhibitors on wet-dog shakes mediated by 5-HT2A receptors in ACTH-treated rats. Pharmacol Biochem Behav 81:65\u201370","journal-title":"Pharmacol Biochem Behav"},{"key":"619_CR30","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0028-3908(94)90133-3","volume":"33","author":"GA Kennett","year":"1994a","unstructured":"Kennett GA, Lightowler S, de Biasi V, Stevens NC, Wood MD, Tulloch IF, Blackburn TP (1994a) Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C\/2B receptor function. Neuropharmacology 33:1581\u20131588","journal-title":"Neuropharmacology"},{"key":"619_CR31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1476-5381.1994.tb14808.x","volume":"111","author":"GA Kennett","year":"1994b","unstructured":"Kennett GA, Wood MD, Glen A, Grewal S, Forbes I, Gadre A, Blackburn TP (1994b) In vivo properties of SB 200646A, a 5-HT2C\/2B receptor antagonist. Br J Pharmacol 111:797\u2013802","journal-title":"Br J Pharmacol"},{"key":"619_CR32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(99)11381-3","volume":"355","author":"JM Kent","year":"2000","unstructured":"Kent JM (2000) SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet 355:911\u2013918","journal-title":"Lancet"},{"key":"619_CR33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0006-3223(95)00632-X","volume":"40","author":"DJ Keuler","year":"1996","unstructured":"Keuler DJ, Altemus M, Michelson D, Greenberg B, Murphy DL (1996) Behavioral effects of naloxone infusion in obsessive\u2013compulsive disorder. Biol Psychiatry 40:154\u2013156","journal-title":"Biol Psychiatry"},{"key":"619_CR34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0306-4530(00)00048-2","volume":"26","author":"S Khanna","year":"2001","unstructured":"Khanna S, John JP, Reddy LP (2001) Neuroendocrine and behavioral responses to mCPP in obsessive\u2013compulsive disorder. Psychoneuroendocrinology 26:209\u2013223","journal-title":"Psychoneuroendocrinology"},{"key":"619_CR35","doi-asserted-by":"crossref","unstructured":"Khazaal Y, Krenz S, Benmebarek M, Zullino DF (2006) Worsening of obsessive-compulsive symptoms under methadone tapering. Prog Neuropsychopharmacol Biol Psychiatry 30:30(7):1350\u20131352 (originally published online 21 April 2006 at http:\/\/www.sciencedirect.com )","DOI":"10.1016\/j.pnpbp.2006.03.001"},{"key":"619_CR36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0022-3565(24)36843-0","volume":"282","author":"MS Kleven","year":"1997","unstructured":"Kleven MS, Assie MB, Koek W (1997) Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist\/5-HT(2A\/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. J Pharmacol Exp Ther 282:747\u2013759","journal-title":"J Pharmacol Exp Ther"},{"key":"619_CR37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4088\/JCP.v66n0312","volume":"66","author":"LM Koran","year":"2005","unstructured":"Koran LM, Aboujaoude E, Bullock KD, Franz B, Gamel N, Elliott M (2005) Double-blind treatment with oral morphine in treatment-resistant obsessive\u2013compulsive disorder. J Clin Psychiatry 66:353\u2013359","journal-title":"J Clin Psychiatry"},{"key":"619_CR38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1034\/j.1600-0773.2003.920504.x","volume":"92","author":"T Koskinen","year":"2003","unstructured":"Koskinen T, Haapalinna A, Sirvio J (2003) Alpha-adrenoceptor-mediated modulation of 5-HT2 receptor agonist induced impulsive responding in a 5-choice serial reaction time task. Pharmacol Toxicol 92:214\u2013225","journal-title":"Pharmacol Toxicol"},{"key":"619_CR39","doi-asserted-by":"crossref","unstructured":"Kraepelin E (1921) Manic-depressive insanity and Paranoia. E&S Livingstone, Edinburgh.","DOI":"10.1097\/00005053-192104000-00057"},{"key":"619_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.410300105","volume":"30","author":"R Kurlan","year":"1991","unstructured":"Kurlan R, Majumdar L, Deeley C, Mudholkar GS, Plumb S, Como PG (1991) A controlled trial of propoxyphene and naltrexone in patients with Tourette\u2019s syndrome. Ann Neurol 30:19\u201323","journal-title":"Ann Neurol"},{"key":"619_CR41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/ajp.151.5.675","volume":"151","author":"JF Leckman","year":"1994","unstructured":"Leckman JF, Walker DE, Goodman WK, Pauls DL, Cohen DJ (1994) \u201cJust right\u201d perceptions associated with compulsive behavior in Tourette\u2019s syndrome. Am J Psychiatry 151:675\u2013680","journal-title":"Am J Psychiatry"},{"key":"619_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1568007043482598","volume":"3","author":"JE Leysen","year":"2004","unstructured":"Leysen JE (2004) 5-HT2 receptors. Curr Drug Targets CNS Neurol Disord 3:11\u201326","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"619_CR43","first-page":"304","volume":"28","author":"MI Lopez-Ibor Alcocer","year":"2000","unstructured":"Lopez-Ibor Alcocer MI, Ortiz Alonso T, Encinas Mejias M, Fernandez A, Maestu F, Lopez-Ibor Alino JJ (2000) New advances in neuroimaging in the diagnosis of obsessive\u2013compulsive disorder. Actas Esp Psiquiatr 28:304\u2013310","journal-title":"Actas Esp Psiquiatr"},{"key":"619_CR44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0893-133X(99)00149-9","volume":"22","author":"DL Mangold","year":"2000","unstructured":"Mangold DL, Peyrot M, Giggey P, Wand GS (2000) Endogenous opioid activity is associated with obsessive\u2013compulsive symptomology in individuals with a family history of alcoholism. Neuropsychopharmacology 22:595\u2013607","journal-title":"Neuropsychopharmacology"},{"key":"619_CR45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(03)01971-X","volume":"474","author":"GJ Marek","year":"2003","unstructured":"Marek GJ (2003) Behavioral evidence for mu-opioid and 5-HT2A receptor interactions. Eur J Pharmacol 474:77\u201383","journal-title":"Eur J Pharmacol"},{"key":"619_CR46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0306-4522(98)00043-8","volume":"86","author":"GJ Marek","year":"1998a","unstructured":"Marek GJ, Aghajanian GK (1998a) 5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation. Neuroscience 86:485\u2013497","journal-title":"Neuroscience"},{"key":"619_CR47","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0006-3223(98)00036-5","volume":"44","author":"GJ Marek","year":"1998b","unstructured":"Marek GJ, Aghajanian GK (1998b) The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis. Biol Psychiatry 44:1118\u20131127","journal-title":"Biol Psychiatry"},{"key":"619_CR48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.npp.1300057","volume":"28","author":"GJ Marek","year":"2003","unstructured":"Marek GJ, Carpenter LL, McDougle CJ, Price LH (2003) Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 28:402\u2013412","journal-title":"Neuropsychopharmacology"},{"key":"619_CR49","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(94)91553-9","volume":"343","author":"BJ McConville","year":"1994","unstructured":"McConville BJ, Norman AB, Fogelson MH, Erenberg G (1994) Sequential use of opioid antagonists and agonists in Tourette\u2019s syndrome. Lancet 343:601","journal-title":"Lancet"},{"key":"619_CR50","first-page":"139","volume":"149","author":"R Meuldijk","year":"1992","unstructured":"Meuldijk R, Colon EJ (1992) Methadone treatment of Tourette\u2019s disorder. Am J Psychiatry 149:139\u2013140","journal-title":"Am J Psychiatry"},{"key":"619_CR51","first-page":"113","volume":"85","author":"JW Mink","year":"2001","unstructured":"Mink JW (2001) Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns? Adv Neurol 85:113\u2013122","journal-title":"Adv Neurol"},{"key":"619_CR52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0006-3223(96)00100-X","volume":"41","author":"HG Nurnberg","year":"1997","unstructured":"Nurnberg HG, Keith SJ, Paxton DM (1997) Consideration of the relevance of ethological animal models for human repetitive behavioral spectrum disorders. Biol Psychiatry 41:226\u2013229","journal-title":"Biol Psychiatry"},{"key":"619_CR53","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1213\/01.ANE.0000108963.77623.A4","volume":"98","author":"J Ogata","year":"2004","unstructured":"Ogata J, Minami K, Uezono Y, Okamoto T, Shiraishi M, Shigematsu A, Ueta Y (2004) The inhibitory effects of tramadol on 5-hydroxytryptamine type 2C receptors expressed in Xenopus oocytes. Anesth Analg 98:1401\u20131406","journal-title":"Anesth Analg"},{"key":"619_CR54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.schres.2004.08.012","volume":"75","author":"D Ongur","year":"2005","unstructured":"Ongur D, Goff DC (2005) Obsessive\u2013compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophr Res 75:349\u2013362","journal-title":"Schizophr Res"},{"key":"619_CR55","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0193-953X(18)30206-5","volume":"15","author":"DL Pauls","year":"1992","unstructured":"Pauls DL (1992) The genetics of obsessive compulsive disorder and Gilles de la Tourette\u2019s syndrome. Psychiatr Clin North Am 15:759\u2013766","journal-title":"Psychiatr Clin North Am"},{"key":"619_CR56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00180825","volume":"88","author":"L Pawlowski","year":"1986","unstructured":"Pawlowski L, Melzacka M (1986) Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram. Psychopharmacology (Berl) 88:279\u2013284","journal-title":"Psychopharmacology (Berl)"},{"key":"619_CR57","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.61.7.720","volume":"61","author":"J Pujol","year":"2004","unstructured":"Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon JM, Deus J, Vallejo J (2004) Mapping structural brain alterations in obsessive\u2013compulsive disorder. Arch Gen Psychiatry 61:720\u2013730","journal-title":"Arch Gen Psychiatry"},{"key":"619_CR58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0024-3205(02)02220-8","volume":"72","author":"MO Rojas-Corrales","year":"2002","unstructured":"Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Mico JA (2002) Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci 72:143\u2013152","journal-title":"Life Sci"},{"key":"619_CR59","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/026988110401800305","volume":"18","author":"MO Rojas-Corrales","year":"2004","unstructured":"Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Mico JA (2004) Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates. J Psychopharmacol 18:404\u2013411","journal-title":"J Psychopharmacol"},{"key":"619_CR60","first-page":"PL175","volume":"63","author":"MO Rojas-Corrales","year":"1998","unstructured":"Rojas-Corrales MO, Gibert-Rahola J, Mico JA (1998) Tramadol induces antidepressant-type effects in mice. Life Sci 63:PL175\u2013180","journal-title":"Life Sci"},{"key":"619_CR61","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00004714-198602000-00029","volume":"6","author":"R Sandyk","year":"1986a","unstructured":"Sandyk R (1986a) Naloxone withdrawal exacerbates Tourette syndrome. J Clin Psychopharmacol 6:58\u201359","journal-title":"J Clin Psychopharmacol"},{"key":"619_CR62","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00314429","volume":"233","author":"R Sandyk","year":"1986b","unstructured":"Sandyk R (1986b) Tourette syndrome: successful treatment with clonidine and oxycodone. J Neurol 233:178\u2013179","journal-title":"J Neurol"},{"key":"619_CR63","first-page":"101","volume":"273","author":"R Schreiber","year":"1995","unstructured":"Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ (1995) (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A\/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 273:101\u2013112","journal-title":"J Pharmacol Exp Ther"},{"key":"619_CR64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/(SICI)1520-6394(1997)6:4<170::AID-DA7>3.0.CO;2-G","volume":"6","author":"NA Shapira","year":"1997a","unstructured":"Shapira NA, Keck PE, Jr., Goldsmith TD, McConville BJ, Eis M, McElroy SL (1997a) Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive\u2013compulsive disorder. Depress Anxiety 6:170\u2013173","journal-title":"Depress Anxiety"},{"key":"619_CR65","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4088\/JCP.v58n0407b","volume":"58","author":"NA Shapira","year":"1997b","unstructured":"Shapira NA, McConville BJ, Pagnucco ML, Norman AB, Keck PE, Jr. (1997b) Novel use of tramadol hydrochloride in the treatment of Tourette\u2019s syndrome. J Clin Psychiatry 58:174\u2013175","journal-title":"J Clin Psychiatry"},{"key":"619_CR66","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.v62n0312b","volume":"62","author":"NA Shapira","year":"2001","unstructured":"Shapira NA, Verduin ML, DeGraw JD (2001) Treatment of refractory major depression with tramadol monotherapy. J Clin Psychiatry 62:205\u2013206","journal-title":"J Clin Psychiatry"},{"key":"619_CR67","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.biopsych.2003.11.010","volume":"55","author":"NA Shapira","year":"2004","unstructured":"Shapira NA, Ward HE, Mandoki M, Murphy TK, Yang MC, Blier P, Goodman WK (2004) A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive\u2013compulsive disorder. Biol Psychiatry 55:553\u2013555","journal-title":"Biol Psychiatry"},{"key":"619_CR68","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1080\/000486700284","volume":"34","author":"C Spencer","year":"2000","unstructured":"Spencer C (2000) The efficacy of intramuscular tramadol as a rapid-onset antidepressant. Aust N Z J Psychiatry 34:1032\u20131033","journal-title":"Aust N Z J Psychiatry"},{"issue":"Suppl 4","key":"619_CR69","first-page":"5","volume":"59","author":"SM Stahl","year":"1998","unstructured":"Stahl SM (1998) Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 59 Suppl 4:5\u201314","journal-title":"J Clin Psychiatry"},{"key":"619_CR70","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0024-3205(02)02345-7","volume":"72","author":"HL Sun","year":"2003","unstructured":"Sun HL, Zheng JW, Wang K, Liu RK, Liang JH (2003) Tramadol reduces the 5-HTP-induced head-twitch response in mice via the activation of mu and kappa opioid receptors. Life Sci 72:1221\u20131230","journal-title":"Life Sci"},{"key":"619_CR71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-0327(99)00021-X","volume":"56","author":"CM Swartz","year":"1999","unstructured":"Swartz CM, Shen WW (1999) Is episodic obsessive compulsive disorder bipolar? A report of four cases. J Affect Disord 56:61\u201366","journal-title":"J Affect Disord"},{"key":"619_CR72","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajmg.b.20170","volume":"127","author":"N Urraca","year":"2004","unstructured":"Urraca N, Camarena B, Gomez-Caudillo L, Esmer MC, Nicolini H (2004) Mu opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics. Am J Med Genet B Neuropsychiatr Genet 127:94\u201396","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"619_CR73","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0091-3057(01)00552-4","volume":"69","author":"SP Vickers","year":"2001","unstructured":"Vickers SP, Easton N, Malcolm CS, Allen NH, Porter RH, Bickerdike MJ, Kennett GA (2001) Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists. Pharmacol Biochem Behav 69:643\u2013652","journal-title":"Pharmacol Biochem Behav"},{"key":"619_CR74","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/070674379704200624","volume":"42","author":"L Warneke","year":"1997","unstructured":"Warneke L (1997) A possible new treatment approach to obsessive\u2013compulsive disorder. Can J Psychiatry 42:667\u2013668","journal-title":"Can J Psychiatry"},{"issue":"Suppl","key":"619_CR75","first-page":"5","volume":"55","author":"MM Weissman","year":"1994","unstructured":"Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wickramaratne PJ et al (1994) The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry 55 Suppl:5\u201310","journal-title":"J Clin Psychiatry"},{"key":"619_CR76","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3565(24)36840-5","volume":"282","author":"DL Willins","year":"1997","unstructured":"Willins DL, Meltzer HY (1997) Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282:699\u2013706","journal-title":"J Pharmacol Exp Ther"},{"key":"619_CR77","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.neuropharm.2006.01.003","volume":"50","author":"LF Xu","year":"2006","unstructured":"Xu LF, Chu WJ, Qing XY, Li S, Wang XS, Qing GW, Fei J, Guo LH (2006) Protopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice models. Neuropharmacology 50:934\u2013940","journal-title":"Neuropharmacology"},{"key":"619_CR78","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.1987.01800230026006","volume":"44","author":"J Zohar","year":"1987","unstructured":"Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive\u2013compulsive disorder. Comparison of patients and healthy controls. Arch Gen Psychiatry 44:946\u2013951","journal-title":"Arch Gen Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-006-0619-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0619-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T22:44:25Z","timestamp":1736635465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-006-0619-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,11]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,12,19]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1007\/s00213-006-0619-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,11]]}}}